UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
LSB Industries
LXU
$698M
| $8.54M | 0.01% |
268,590
+55,380
| +26% | +$1.51M |
|
877
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
| – | – |
0
| – | – |
|
|
CAVM
878
DELISTED
Cavium, Inc.
CAVM
| $8.51M | 0.01% |
120,198
-85,100
| -41% | -$5.52M |
|
879
Haemonetics
HAE
$3.89B
| $8.45M | 0.01% |
188,050
-42,637
| -18% | -$1.78M |
|
880
iShares Russell 1000 Growth ETF
IWF
$128B
| $8.27M | 0.01% |
334,380
+164,384
| +97% | +$4.02M |
|
881
Allegion
ALLE
$14.4B
| $8.19M | 0.01% |
133,797
-17,302
| -11% | -$989K |
|
882
Theravance Biopharma
TBPH
$877M
| $8.18M | 0.01% |
471,712
+237,900
| +102% | +$4.36M |
|
|
SGMO
883
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $8.18M | 0.01% |
521,698
-3,000
| -0.6% | -$46.4K |
|
884
Cogent Communications
CCOI
$481M
| $8.18M | 0.01% |
231,499
-4,300
| -2% | -$157K |
|
|
RCPT
885
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $8.18M | 0.01% |
49,600
+1,100
| +2% | +$139K |
|
|
WCG
886
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.18M | 0.01% |
89,399
-30,500
| -25% | -$2.55M |
|
|
XOMA
887
DELISTED
Xoma
XOMA
| $8.16M | 0.01% |
112,045
+20,250
| +22% | +$1.49M |
|
|
MNDT
888
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $8.15M | 0.01% |
207,755
+1,395
| +0.7% | +$53.9K |
|
|
BRS
889
DELISTED
Bristow Group, Inc.
BRS
| $8.07M | 0.01% |
148,212
-2,705
| -2% | -$160K |
|
890
iShares Russell 3000 ETF
IWV
$20.3B
| $8.07M | 0.01% |
65,148
-24,400
| -27% | -$3.01M |
|
|
NFX
891
DELISTED
Newfield Exploration
NFX
| $8.07M | 0.01% |
229,875
-3,263
| -1% | -$98.9K |
|
892
Wabash National
WNC
$514M
| $8.02M | 0.01% |
568,646
-11,100
| -2% | -$150K |
|
|
SWI
893
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $8M | 0.01% |
156,122
-6,400
| -4% | -$318K |
|
|
N
894
DELISTED
Netsuite Inc
N
| $8M | 0.01% |
86,224
-2,665
| -3% | -$264K |
|
895
Ciena
CIEN
$58B
| $7.98M | 0.01% |
413,147
-6,900
| -2% | -$137K |
|
|
MTEM
896
DELISTED
Molecular Templates, Inc.
MTEM
| $7.9M | 0.01% |
11,798
| – | – |
|
897
Ryder
R
$10.1B
| $7.87M | 0.01% |
82,894
-768
| -0.9% | -$70.6K |
|
|
NGD
898
DELISTED
New Gold Inc
NGD
| $7.82M | 0.01% |
2,329,564
-3,813
| -0.2% | -$15K |
|
|
TIME
899
DELISTED
Time Inc.
TIME
| $7.82M | 0.01% |
348,397
-2,878,907
| -89% | -$68.9M |
|
|
OA
900
DELISTED
Orbital ATK, Inc.
OA
| $7.8M | 0.01% |
101,804
+87,405
| +607% | +$8.27M |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.